Gold prices rebound as risk-off mood grips markets; US payroll data awaited
Investing.com - Kepler Cheuvreux upgraded Virbac SA (EPA:VIRB) (OTC:VRBCF) from Hold to Buy on Friday, while raising its price target to EUR415.00 from EUR390.00.
The upgrade comes as the animal health company shows reaccelerated growth across all regions, with cost headwinds fading and currency pressures easing, according to the research firm.
Kepler Cheuvreux noted that the combination of top-line momentum and disciplined cost management has supported Virbac ’s recent fiscal year guidance upgrade and restored confidence in the group’s ability to achieve its 20% medium-term margin target.
The firm highlighted improving visibility and receding operational volatility as factors contributing to renewed upside potential for the company.
Kepler Cheuvreux specifically pointed to expectations for more visible margin expansion in 2026 as part of its rationale for the more bullish outlook on Virbac shares.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.